A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Clinical trial NCT03053271 · TERMINATED
Trial details
- NCT number
- NCT03053271
- Sponsor
- Millendo Therapeutics US, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-13
- Primary completion
- 2019-06-17
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.